Open original FDA record ↗Recall record
- FDA identifier
- Z-1631-2018
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- May 4, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Randox has now released further steps to avoid contamination of the Lipase Assay on Rx instruments.
Source facts
- Action
- On March 1, 2018 Randox Laboratories Ltd. sent a Urgent Medical Device Correction Notification to affected customers. These customers were instructed to: 1) Update the user manual for the RX Instrument with the attached technical bulletin; 2) Replace the Instructions for Use contained within the kit with the revised version; 3) Discuss the contents of this notice with your Medical Director; 4) Complete and return the vigilance response section of this form to technical.services@randox..com within five working days; 5) Send a copy of the FSN to all affected customers and to those who need to be aware within your organization. Customer with questions may contact Randox Technical Services via e-mail technical.services@randox.com or by phone +44 (0) 28 9445 1070
- Initiated
- 2018-03-02
- Root cause
- Under Investigation by firm
- Terminated
- 2019-04-11
- Distribution
- US Nationwide Distribution in the states of West Virginia and Puerto Rico
- Recall number
- Z-1631-2018
- Recall status
- Terminated
- CDRH record ID
- 163324
- FDA record created
- 2018-05-04
- Recall event number
- 79767